JARED

Joint Action on REspiratory Diseases

Chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases (ILDs) and occupational lung diseases affect the airways and other structures of the lungs and pose a serious public health problem throughout Europe.

The aim of this project is to strengthen and renew the European Union’s efforts to reduce chronic lung diseases through innovative solutions. The project aims to promote early detection of diseases and support independent management of the condition.

The European consortium

The project brings together 35 organisations from 14 countries in the fields of healthcare, research and education with the aim of improving the prevention of these diseases, promoting innovative treatment methods and raising awareness in European society of the importance of lung health, as well as improving healthcare by providing a better quality of life for patients. JARED is coordinated by the National Korányi Institute for Pulmonology (OKPI).

Role of INCLIVA

INCLIVA is part of the node of Spanish affiliated entities under the coordination of the Andalusian Health Service.

Summarising the project

The Joint Action on REspiratory Diseases (JARED) project, coordinated by the National Korányi Institute for Pulmonology (OKPI), is an international collaboration supported by the European Commission. In this project, 35 institutes working in field of healthcare, education and research from 14 countries come together for a common goal: the effective prevention and treatment of Chronic Respiratory Diseases (CRD). The main focus point of this project is based on CRDs of the greatest public health importance, such as asthma, COPD, interstitial lung diseases (ILD), and occupational lung diseases. But the emphasis is also given to lung conditions associated with certain infections.

One of the main objectives of this project is to connect member states across the EU and enhance joint action to prevent, detect and treat these kinds of diseases. In the framework of JARED, several innovative approaches are also implemented, such as digital health solutions that allow patients to monitor and manage their own condition on a better way, especially in remote or disadvantaged regions. In addition to all these, the project pays special attention to disadvantaged groups, such as ethnic minorities and rural populations, who are often at higher risk from the perspective of developing CRDs.

Other key areas of the project include supporting preventive vaccinations, reducing smoking, improving indoor air quality, preventing occupational respiratory diseases, increasing early detection of respiratory diseases, developing multidisciplinary patient care, and developing respiratory rehabilitation with a self-treatment support. One of the novelties of JARED is that it integrates lung cancer screening and COPD early detection programs, which make the treatment of high-risk individuals more effective.

Summarising all above, JARED aims to significantly reduce the burden of respiratory diseases in Europe, improve early detection and support patient self-treatment, especially among the most vulnerable social groups. The project also creates large-scale collaboration between member states of the EU. Finally, its mission is to sustainably reduce the incidence of CRD, significantly improve the quality of life for patients and integrate research findings into health policy and practice.

Institutions that are part of the consortium

Country Institute
Hungary National Korányi Institute of Pulmonology
The National Center for Public Health and Pharmacy
Borsod-Abaúj-Zemplén County Central Hospital and University Teaching Hospital

DEBRECENI EGYETEM

Greece 1st Regional Health Authority of Attica
Sotiria Hospital
Spain Andalusian Health Service
Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana
Fundación Instituto de Investigación Marqués de Valdecilla
Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Fundación Investigación Biomédica Hospital Universitario 12 de Octubre
Fundación para la Investigación de Málaga en Biomedicina y Salud
Poland National Health Fund of Poland
Medical University of Warsaw
Finland The Finnish Institute for Health and Welfare
Finnish Lung Health Association
Denmark Municipality of Aarhus
Croatia University Hospital Centre Zagreb
Italy The Istituto Superiore di Sanità
Università Politecnica delle Marche
University of Florence
University of Naples Federico II
Latvia Centre for Disease Prevention and Control
Pauls Stradins Clinical University Hospital
Riga Stradins University
Lithuania Ministry of Health of the Republic of Lithuania
National Public Health Centre
Vilnius University Hospital Santaros Klinikos
Lithuanian University of Health Sciences
Moldova Institute of Phthisiopneumology ,,Chiril Draganiuc”
Portugal Ministerio Da Saude – Republica Portuguesa
National Institute of Health Dr. Ricardo Jorge
Unidade Local de Saúde de Santa Maria
Romania Marius Nasta” Institute of Pneumophthiology
Iceland Reykjalundur
Czech Republic MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY
Ukraine National institute of phthisiology and pulmonology named after F. G. Yanovsky of the NAMS of Ukraine, SI

JARED project GA N. 01183391. Funded by the European Union. The views and opinions expressed are solely those of the author(s) and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

PROGRAMME

EU4Health

PRINCIPAL INVESTIGATOR

Dr. Jaime Signes Costa

ROL

Affiliated entity

FUNDING

6,000,000 euro

Funding allocated to INCLIVA:

10,700 euro

START/END

01.12.2024 – 30.11.2027

SOCIAL MEDIA